We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our
Cookie Policy
.
Accept
Label
Search
SKIP TO CONTENT
SKIP NAVIGATION
Drug News
Trending
Commercial Operations
GMPs
FDA Enforcement Actions
Inspections and Audits
Postmarket Safety
Quality
Regulatory Affairs
Research and Development
Submissions and Approvals
FDAnews
Device News
Trending
Commercial Operations
FDA Enforcement Actions
Inspections and Audits
Postmarket Safety
Quality
Regulatory Affairs
Research and Development
Submissions and Approvals
FDAnews
Books
FDAnews Books Library
Drug Books
Device Books
Training/Events
Webinar Training Pass
Events
Webinar Recordings
Resources
Form 483s Database
FDA Approved Drugs
CenterWatch
WCG Clinical
Sign In
Create Account
Sign Out
My Account
Home
»
Authors
» Yvesna Blaise
Yvesna Blaise
Products
PRODUCTS
Baxalta US, Inc.
Yvesna Blaise
,
Janet L. Bowen
, and
Nimmy Mathews
Price:
$117.00
View
Pro-Blending, LLC
Yvesna Blaise
Price:
$117.00
View
Hikma Pharmaceuticals USA, Inc.
Yvesna Blaise
Price:
$117.00
View
Dead Sea Periclase
Yvesna Blaise
and
Walden H. Lee
Price:
$117.00
View
Taro Pharmaceutical Industries, Ltd.
Yvesna Blaise
and
Walden H. Lee
Price:
$117.00
View
InvaTech Pharma Solutions, LLC
Yvesna Blaise
Price:
$117.00
View
Unither Manufacturing LLC
Yvesna Blaise
Price:
$117.00
View
Sun Pharmaceutical Industries, Inc.
Yvesna Blaise
and
Parul M. Patel
Price:
$117.00
View
Glatt Air Techniques, Inc.
Yvesna Blaise
and
Unnee Ranjan
Price:
$117.00
View
Leading Pharma, LLC
Yvesna Blaise
,
Niketa Patel
, and
Guerlain Ulysse
Price:
$117.00
View
Upcoming Events
21
Oct
MAGI@home Clinical Research Conference 2024
Featured Products
From QSR to QMSR: Meeting FDA’s New Requirements
FDA Oversight of Laboratory-Developed Tests — The Impact of the Final Rule
Featured Stories
Risk of 10 Obesity-Driven Cancers Reduced by GLP-1s, Study Says
Three Device Areas Added to CDRH’s Device-Advancing TAP Program
Third Alzheimer’s Drug Gets FDA Approval, Just as Diagnostic Criteria Expand
Draft Guidance Covers Using URRAs in Combo Product Applications
The Revised ICH E8:
A Guide to New Clinical Trial Requirements
Learn More
